Nuclear insulin-like growth factor 1 receptor phosphorylates proliferating cell nuclear antigen and rescues stalled replication forks after DNA damage-Reference-Cited by-同舟云学术

Nuclear insulin-like growth factor 1 receptor phosphorylates proliferating cell nuclear antigen and rescues stalled replication forks after DNA damage

Published:2017-11 Issue:44 Volume:292 Page:18227-18239
ISSN:0021-9258
Container-title:Journal of Biological Chemistry
language:en
Short-container-title:Journal of Biological Chemistry

Author:

Waraky Ahmed,Lin Yingbo,Warsito Dudi,Haglund Felix,Aleem Eiman,Larsson Olle

Publisher

Elsevier BV

Subject

Cell Biology,Molecular Biology,Biochemistry

Reference53 articles.

1. The insulin and insulin-like growth factor receptor family in neoplasia: an update;Pollak;Nat. Rev. Cancer,2012

2. SUMOylation mediates the nuclear translocation and signaling of the IGF-1 receptor;Sehat;Sci. Signal,2010

3. Nuclear IGF1R is a transcriptional co-activator of LEF1/TCF;Warsito;EMBO Rep,2012

4. Nuclearly translocated insulin-like growth factor 1 receptor phosphorylates histone H3 at tyrosine 41 and induces SNAI2 expression via Brg1 chromatin remodeling protein;Warsito;Oncotarget,2016

5. Structural and functional similarities of prokaryotic and eukaryotic DNA polymerase sliding clamps;Kelman;Nucleic Acids Res,1995

Cited by 29 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Growth hormone and radiation therapy: friend, foe, or both?;Endocrine-Related Cancer;2024-01-04

2. Effects and potential mechanisms of IGF1/IGF1R in the liver fibrosis: A review;International Journal of Biological Macromolecules;2023-11

3. IGF-1R targeting in cancer – does sub-cellular localization matter?;Journal of Experimental & Clinical Cancer Research;2023-10-20

4. IGF1R-phosphorylated PYCR1 facilitates ELK4 transcriptional activity and sustains tumor growth under hypoxia;Nature Communications;2023-09-30

5. Molecularly Defined Subsets of Ewing Sarcoma Tumors Differ in Their Responses to IGF1R and WEE1 Inhibition;Clinical Cancer Research;2022-11-17